Cardiac Abnormalities in Acromegaly Patients: A Cardiac Magnetic Resonance Study

Table 5

Literature review of the studies that applied CMRi in acromegaly patients.

Year	First author	Patients enrolled	LVH (%)	LVMi (g/m^2)	IVSH (%)	LVSD (%)	LVEF (%)	RVSD (%)	MCF (%)
2008	Bogazzi F.	14	72	77 ± 9	0	0	67 ± 11	NA	0
2008	Gouya H.	15	27	77 ± 5.3	NA	0	68 ± 6.6	NA	NA
2010	Andreassen M.	8	37.5	92	NA	12.5	67	NA	NA
2015	Silva C. M.	40	5	61.7 ± 18.8	17.5	0	61.8 ± 9.2	NA	13.5
2016	Warszawski L.	36	8	61.8 ± 19.6	NA	0	NA	NA	12
2018	Present study	61	26.2	60.0 ± 22.8	27.9	8.2	59.9 ± 10.0	9.8	14.8

CMRi, cardiac magnetic resonance imaging; LVH, left ventricular hypertrophy; LVMi, left ventricular mass index; IVSH, interventricular septum hypertrophy; LVSD, left ventricular systolic dysfunction; LVEF, left ventricular ejection fraction; RVSD, right ventricular systolic dysfunction; MCF, myocardial fibrosis; NA, not available.